Comparable pharmacokinetics of generic indinavir (Inhibisam) versus brand indinavir (Crixivan) when boosted with ritonavir.
Zala
Carlos
C
Alexander
Christopher S
CS
Ochoa
Claudia
C
Guillemi
Silvia
S
Ting
Lillian S
LS
Bonner
Simon
S
Cahn
Pedro
P
Harrigan
P Richard
PR
Montaner
Julio S G
JS
D000328:Adult; D019380:Anti-HIV Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016568:Drugs, Generic / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019469:Indinavir / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019438:Ritonavir / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D016568:Drugs, Generic; D019469:Indinavir; D019438:Ritonavir